𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions

✍ Scribed by J-D Maréchal; C A Kemp; G C K Roberts; M J I Paine; C R Wolf; M J Sutcliffe

Book ID
110009824
Publisher
Nature Publishing Group
Year
2009
Tongue
English
Weight
345 KB
Volume
153
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug disposition of chiral and achiral d
Drug disposition of chiral and achiral drug substrates metabolized by cytochrome P450 2D6 isozyme: case studies, analytical perspectives and developmental implications
✍ Nuggehally R. Srinivas 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 1 views

## Abstract The concepts of drug development have evolved over the last few decades. Although number of novel chemical entitities belonging to varied classes have made it to the market, the process of drug development is challenging, intertwined as it is with complexities and uncertainities. The in

No evidence of increased adverse drug re
No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline
✍ Rebecca L. Roberts; Roger T. Mulder; Peter R. Joyce; Suzanne E. Luty; Martin A. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

## Abstract The polymorphic enzyme cytochrome P450 CYP2D6 is involved in the metabolism of many antidepressants, including nortriptyline and fluoxetine. Some 7%–10% Caucasians have inactivating mutations in both alleles of the __CYP2D6__ gene, and are referred to as poor metabolizers (PMs). Several